T1	Participants 320 401	patients with supraventricular tachyarrhythmias (heart rate greater than 120 bpm)
T2	Participants 459 571	Seventy-one patients were randomized to receive either esmolol (n = 36) or placebo (n = 35) as initial treatment
T3	Participants 1038 1113	Four patients (6%) converted to normal sinus rhythm during esmolol infusion
T4	Participants 1377 1427	hypotension which occurred in eight patients (12%)
